1-6 of 6
Peter Smith
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival

Stefanie Chan, Praveen Sridhar, Rory Kirchner, Ying Jie Lock, Zach Herbert, Silvia Buonamici, Peter Smith, Judy Lieberman, Fabio Petrocca
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (12): 2849–2861.
https://doi.org/10.1158/1535-7163.MCT-17-0461
Published: 03 December 2017
View article titled, Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
Open the PDF for Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival in another window
Includes: Supplementary data
Journal Articles

Abstract C8: Targeting MCL1-dependent cancers with SF3B splicing modulators

Daniel Aird, Ermira Pazolli, Craig Furman, Linda Lee, Kaiko Kunii, Eun Sun Park, Craig Karr, Betty Chan, Michelle Aicher, Silvia Buonamici, John Yuan Wang, Jacob Feala, Lihua Yu, Markus Warmuth, Peter Smith, Peter Fekkes, Ping Zhu, Baudouin Gerard, Yoshiharu Mizui, Laura Corson
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): C8.
https://doi.org/10.1158/1535-7163.TARG-15-C8
Published: 01 December 2015
View article titled, Abstract C8: Targeting MCL1-dependent cancers with SF3B splicing modulators
Journal Articles

Abstract C82: Identification and preclinical characterization of inhibitors of the ubiquitin-activating enzymes UBA1 and UBA6.

Neil Bence, Paul Fleming, Jeff Ciavarri, Michael Milhollen, Sai Pulukuri, Marc Hyer, Tary Traore, Jessica Huck, Derek Tou, Darshan Sappal, Kara Hoar, James Gavin, Yu Yang, James Brownell, Peter Smith, Lawrence Dick, Petter Veiby, Mark Manfredi, Christopher Claiborne
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): C82.
https://doi.org/10.1158/1535-7163.TARG-11-C82
Published: 12 November 2011
View article titled, Abstract C82: Identification and preclinical characterization of inhibitors of the ubiquitin-activating enzymes UBA1 and UBA6.
Journal Articles

Abstract B207: Prostate specific membrane antigen is a diagnostic marker of response to allosteric androgen receptor inhibition

Michael J. Evans, Peter Smith‐Jones, John Wongvipat, Steven M. Larson, Charles L. Sawyers
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): B207.
https://doi.org/10.1158/1535-7163.TARG-09-B207
Published: 10 December 2009
View article titled, Abstract B207: Prostate specific membrane antigen is a diagnostic marker of response to allosteric androgen receptor inhibition
Journal Articles

Antitumor activity of MLN4924, a novel small molecule inhibitor of Nedd8-activating enzyme, in pre-clinical models of lymphoma

Peter Smith, Michael Milhollen, Tary Traore, Julie Zhang, Allison Berger, Jie Yu, James Garnsey, Steve Langston, Teresa Soucy
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): C231.
Published: 01 November 2007
View article titled, Antitumor activity of MLN4924, a novel small molecule inhibitor of Nedd8-activating enzyme, in pre-clinical models of lymphoma
Journal Articles

Preclinical evaluation of MLN4924, the first small molecule inhibitor of NEDD8-activating enzyme (NAE) for the treatment of cancer

Teresa Soucy, Peter Smith, Michael Milhollen, Allison Berger, Barbara Davis, Hua Yang, Anya Lublinsky, Julie Zhang, Tary Traore, Usha Narayanan, Jie Yu, James Garnsey, James Gavin, Gabriel Weatherhead, Courtney Cullis, Edward Olhava, Stepan Vyskocil, Mark Rolfe, Steven Langston
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (11_Supplement): B280.
Published: 01 November 2007
View article titled, Preclinical evaluation of MLN4924, the first small molecule inhibitor of NEDD8-activating enzyme (NAE) for the treatment of cancer